Sen, A., Toniolo, S., Tai, X. Y., Akinola, M., Symmonds, M., Mura, S., . . . Husain, M. Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: A pilot, double‐blind placebo‐controlled crossover trial. Wiley.
Chicago Style (17th ed.) CitationSen, Arjune, et al. Safety, Tolerability, and Efficacy Outcomes of the Investigation of Levetiracetam in Alzheimer's Disease (ILiAD) study: A Pilot, Double‐blind Placebo‐controlled Crossover Trial. Wiley.
MLA (9th ed.) CitationSen, Arjune, et al. Safety, Tolerability, and Efficacy Outcomes of the Investigation of Levetiracetam in Alzheimer's Disease (ILiAD) study: A Pilot, Double‐blind Placebo‐controlled Crossover Trial. Wiley.
Warning: These citations may not always be 100% accurate.